关注
Haydar Celik
Haydar Celik
Director, Precision Medicine and Digital Health
在 bms.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model
TZ Minas, D Surdez, T Javaheri, M Tanaka, M Howarth, HJ Kang, J Han, ...
Oncotarget 8 (21), 34141, 2017
932017
Evaluation of the protective effects of quercetin, rutin, naringenin, resveratrol and trolox against idarubicin-induced DNA damage
H Çelik, E Arinç
University of Alberta Libraries, 2010
712010
A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model
S Rahim, T Minas, SH Hong, S Justvig, H Çelik, YS Kont, J Han, ...
PLoS One 9 (12), e114260, 2014
702014
Ezrin inhibition up-regulates stress response gene expression and blocks osteosarcoma metastasis
H Çelik, G Bulut, J Han, GT Graham, TZ Minas, EJ Conn, SH Hong, ...
Cancer Research 76 (14 Supplement), 2446, 2016
54*2016
Ezrin inhibition up-regulates stress response gene expression
H Çelik, G Bulut, J Han, GT Graham, TZ Minas, EJ Conn, SH Hong, ...
Journal of Biological Chemistry, 2016
542016
Inhibitory effects of dietary flavonoids on purified hepatic NADH-cytochrome b5 reductase: Structure–activity relationships
H Çelik, M Koşar
Chemico-biological interactions 197 (2-3), 103-109, 2012
522012
Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia
H Çelik, KE Lindblad, B Popescu, G Gui, M Goswami, J Valdez, ...
Blood Advances 4 (2), 367-379, 2020
402020
Ezrin binds to DEAD-box RNA helicase DDX3 and regulates its function and protein level
H Çelik, KP Sajwan, AV Pai, BJ Marsh, YS Kont, S Rahim, J Han, T Minas, ...
Cancer Research 75 (15 Supplement), 3269, 2015
392015
Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue
EM Cortés-Malagón, J Bonilla-Delgado, J Díaz-Chávez, ...
Virology 447 (1-2), 155-165, 2013
392013
Ezrin enhances EGFR signaling and modulates erlotinib sensitivity in non–small cell lung cancer cells
Y Saygideğer-Kont, TZ Minas, H Jones, S Hour, H Çelik, I Temel, J Han, ...
Neoplasia 18 (2), 111-120, 2016
342016
Bioreduction of idarubicin and formation of ROS responsible for DNA cleavage by NADPH-cytochrome P450 reductase and its potential role in the antitumor effect
H Çelik, E Arinç
Journal of Pharmacy & Pharmaceutical Sciences 11 (4), 68-82, 2008
332008
Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99
H Çelik, M Sciandra, B Flashner, E Gelmez, N Kayraklıoğlu, ...
Oncogene, 1, 2018
322018
YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model
TZ Minas, J Han, T Javaheri, SH Hong, M Schlederer, Y Saygideğer-Kont, ...
Oncotarget 6 (35), 37678, 2015
292015
Identification of novel ezrin inhibitors targeting metastatic osteosarcoma by screening open access malaria box
H Çelik, SH Hong, DD Colón-López, J Han, YS Kont, TZ Minas, M Swift, ...
Molecular Cancer Therapeutics, 2015
282015
Biochemical characteristics of purified beef liver NADPH–cytochrome P450 reductase
E Arinç, H Ļelik
Journal of Biochemical and Molecular Toxicology 16 (6), 286-297, 2002
222002
Early synergistic interactions between the HPV16‑E7 oncoprotein and 17β-oestradiol for repressing the expression of Granzyme B in a cervical cancer model
JA Munguía-Moreno, J Díaz‑Chavéz, E García-Villa, ME Albino-Sanchez, ...
International journal of oncology 53 (2), 579-591, 2018
212018
In vitro effects of myricetin, morin, apigenin,(+)-taxifolin,(+)-catechin,(−)-epicatechin, naringenin and naringin on cytochrome b5 reduction by purified NADH-cytochrome b5 …
H Çelik, M Koşar, E Arinç
Toxicology 308, 34-40, 2013
152013
Human papillomavirus type 16 E7 oncoprotein upregulates the retinoic acid receptor-beta expression in cervical cancer cell lines and K14E7 transgenic mice
J Gutiérrez, E García-Villa, R Ocadiz-Delgado, EM Cortés-Malagón, ...
Molecular and Cellular Biochemistry, 1-12, 2015
102015
Mechanisms and involvements of NADPH-cytochrome P450 reductase and NADH-cytochrome b5 reductase in mitomycin c and idarubicin promoted DNA damage and" ros" formation: A study …
H Celik, E Arinc
62006
Comparison of the in vitro DNA-damaging potential of the two anticancer drugs idarubicin and mitomycin C in the presence of NADPH-cytochrome P450 reductase
H Celik, E Arinc
62006
系统目前无法执行此操作,请稍后再试。
文章 1–20